IP Library Granted Patent US 11,045,512
Granted Patent B2
US 11,045,512 · App. 16/229,471 · Granted Jun 29, 2021

Herbal composition for the treatment and management of Thyroid dysfunction and method of preparation thereof

Inventor: M Vijayabhanu Shetty (Manipal, IN)
Assignee: Muniyal Ayurvedic Research Centre
A61K36/48A61K9/20A61K9/205A61K33/00A61K33/26A61K33/30A61K33/34A61K35/04A61K35/614A61K36/185A61K36/328A61P5/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,512
App. No.
16/229,471
Granted
Jun 29, 2021
Kind
B2
Abstract

Herbal composition for treatment and management of Thyroid dysfunction and method of preparation are disclosed herein. The disclosed composition including herbs and bhasmas may be used to treat Thyroid dysfunction and associated complications such as Hashimoto's thyroiditis, hyperthyroidism, hypothyroidism, Goiter, Thyrotoxicosis, Graves' disease, autoimmune thyroiditis etc. The method disclosed herein may be used as the main line of treatment or as supportive medication.

Claims (12)

1. An oral composition for treatment and management of thyroid dysfunction and associated complications, comprising therapeutically effective amount of Bauhinia variegata, Crataeva nurvala, Commiphora mukul, Emblica officinalis, Terminalia chebula, Terminalia bellerica, Zingiber officinale, Piper nigrum, Piper longum, Cinnamomum zeylanica, Elettaria cardamomum, Cinnamomum tamala, Glycyrrhiza glabra, Boerhavia diffusa, Adhatoda vasica, Vinca rosea, Withania somnifera, Sida cordifolia, Tinospora cordifolia, Ocimum sanctum, Curcuma longa, Moringa oleifera, Aristolochia indica, Azadirachta indica, Eclipta alba, Shilajit , at least one Bhasma, and a suitable excipient.

2. The composition as claimed in claim 1 , wherein said Bhasma is selected from a group consisting of Swarna Makshika bhasma, Abhraka bhasma, Loha bhasma, Trivanga bhasma and Pravala bhasma.

3. The composition as claimed in claim 1 , wherein said Bauhinia variegata is present in an amount ranging from 10 to 14 wt % of the total weight of the composition.

4. The composition as claimed in claim 1 , wherein said Crataeva nurvala is present in an amount ranging from 10 to 14 wt % of the total weight of the composition.

5. The composition as claimed in claim 1 , wherein said Commiphora mukul is present in an amount ranging from 8 to 12 wt % of the total weight of the composition.

6. The composition as claimed in claim 1 , wherein said Shilajit is present in an amount ranging from 2 to 6 wt % of the total weight of the composition.

7. The composition as claimed in claim 2 , wherein said composition comprises Swarna Makshika bhasma in an amount of ≤2 wt %, Abhraka bhasma in an amount of ≤2 wt %, Loha bhasma in an amount of ≤2 wt %, Trivanga bhasma in an amount of ≤2 wt % and Pravala bhasma in an amount of ≤2 wt %, of the total weight of the composition.

8. The composition as claimed in claim 1 , wherein said composition comprises Emblica officinalis in an amount ranging from 2 to 6 wt %, Terminalia chebula in an amount of ≤3 wt %, Terminalia bellerica in an amount of ≤3 wt %, Zingiber officinale in an amount of ≤3 wt %, Piper nigrum in an amount of ≤3 wt %, Piper longum in an amount of ≤3 wt %, Cinnamomum zeylanica in an amount of ≤3 wt %, Elettaria cardamomum in an amount of ≤3 wt %, Cinnamomum tamala in an amount of ≤3 wt %, Glycyrrhiza glabra in an amount of ≤3 wt %, Boerhavia diffusa in an amount of ≤3 wt %, Adhatoda vasica in an amount of ≤3 wt %, Vinca rosea in an amount of ≤3 wt %, Withania somnifera in an amount of ≤3 wt %, Sida cordifolia in an amount of ≤3 wt %, Tinospora cordifolia in an amount of ≤3 wt %, Ocimum sanctum in an amount of ≤3 wt %, Curcuma longa in an amount of ≤3 wt %, Moringa oleifera in an amount of ≤3 wt %, Aristolochia indica in an amount of ≤3 wt %, Azadirachta indica in an amount of ≤3 wt % and Eclipta alba in an amount of ≤2 wt %, of the total weight of the composition.

9. The composition as claimed in claim 1 , wherein said suitable excipient is gum acacia present in an amount in the range of 8 to 12 wt % of the total weight of the composition.

10. The composition as claimed in claim 1 , comprising Bauhinia variegata in an amount ranging from 10 to 14 wt %, Crataeva nurvala in an amount ranging from 10 to 14 wt %, Commiphora mukul in an amount ranging from 8 to 12 wt %, Shilajit in an amount ranging from 2 to 6 wt %, Swarna Makshika bhasma in an amount of ≤2 wt %, Abhraka bhasma in an amount of ≤2 wt %, Loha bhasma in an amount of ≤2 wt %, Trivanga bhasma in an amount of ≤2 wt % Pravala bhasma in an amount of ≤2 wt %, Emblica officinalis in an amount ranging from 2 to 6 wt %, Terminalia chebula in an amount of ≤3 wt %, Terminalia bellerica in an amount of ≤3 wt %, Zingiber officinale in an amount of ≤3 wt %, Piper nigrum in an amount of ≤3 wt %, Piper longum in an amount of ≤3 wt %, Cinnamomum zeylanica in an amount of <3 wt %, Elettaria cardamomum in an amount of ≤3 wt %, Cinnamomum tamala in an amount of ≤3 wt %, Glycyrrhiza glabra in an amount of ≤3 wt %, Boerhavia diffusa in an amount of ≤3 wt %, Adhatoda vasica in an amount of ≤3 wt %, Vinca rosea in an amount of ≤3 wt %, Withania somnifera in an amount of ≤3 wt %, Sida cordifolia in an amount of ≤3 wt %, Tinospora cordifolia in an amount of ≤3 wt %, Ocimum sanctum in an amount of ≤3 wt %, Curcuma longa in an amount of ≤3 wt %, Moringa oleifera in an amount of ≤3 wt %, Aristolochia indica in an amount of ≤3 wt %, Azadirachta indica in an amount of ≤3 wt %, and Eclipta alba in an amount of ≤2 wt %, of the total weight of the composition; and a suitable excipient.

11. The composition as claimed in claim 10 , wherein said composition is in the form of a tablet.

12. The composition as claimed in claim 11 , wherein said tablet is in the form of 500 mg tablet.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2021
From: SHETTY, M VIJAYABHANU, DR.
To: MUNIYAL AYURVEDIC RESEARCH CENTRE
Reel/Frame 056366/0746 →
Continuity (2)
Provisional Application 62609953 · Dec 22, 2017
Related Publication 20190111094A1 · Apr 18, 2019